Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1Sarcoma 1Kidney Transplantation 1Advanced HR - Positive, HER2 - Negative Breast Cancer 1

Interventions

Fluorodeoxyglucose F18 4Drug Therapy 2nimotuzumab 1apatinib 1Ultrasonography, Doppler 1Ultrasonography 1Sirolimus 1Re-Irradiation 1Radiosurgery 1RE1-silencing transcription factor 1Proton Therapy 1Ink 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Solid Tumor × Sirolimus × Clear all
NCT02449564 2018-01-17

The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

Samsung Medical Center

Phase NA Completed
5 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡